In summary, the above evidence of CD8+ T-cell abnormalities points to an anergic CD8+ T-cell compartment in sarcoidosis that results in several detectable biomarkers indicating disease presence, severity, and treatment strategies. The gene discussed is CD8A; the disease is sarcoidosis.